Biblio Discovery — Demo Discovery Service

12 results for "Tzu-Min Lin"

Showing 1–12 · 0.44 seconds · RSS

  1. Journal Article

    Vision-Based Instant Measurement System for Driver Fatigue Monitoring

    Yin-Cheng Tsai; Peng-Wen Lai; Po-Wei Huang et al.

    IEEE Access, Vol. 8 · 2020 · English · DOAJ Scopus

    In this paper, a vision-based physiological signal measurement system is proposed to instantly measure driver fatigue. A remote photoplethysmography (rPPG) signal is a type of physiological signal measured by a camera without any contact device, and it also retains the characteristics of the PPG…

  2. Journal Article Full text

    Autoimmune rheumatic diseases increase dementia risk in middle-aged patients: A nationwide cohort study

    Tzu-Min Lin; Wei-Sheng Chen; Jau-Jiuan Sheu et al.

    PLOS ONE, Vol. 13 No. 1 · 2018 · English · PLOS Scopus

    Objective: Dementia is a common neurological disease that substantially affects public health. A previous study revealed that dementia occurs when the body’s immune system attacks the cells of the brain, indicating that dementia may be similar to autoimmune rheumatic diseases (ARDs). In the current…

    Also available at: DOAJ

  3. Journal Article

    Identification of tophi in ultrasound imaging based on transfer learning and clinical practice

    Tzu-Min Lin; Hsiang-Yen Lee; Ching-Kuei Chang et al.

    Scientific Reports, Vol. 13 No. 1 · 2023 · English · DOAJ Scopus

    Abstract Gout is a common metabolic disorder characterized by deposits of monosodium urate monohydrate crystals (tophi) in soft tissue, triggering intense and acute arthritis with intolerable pain as well as articular and periarticular inflammation. Tophi can also promote chronic inflammatory and…

  4. Journal Article

    Association of interferon-based therapy with risk of autoimmune diseases in patients with chronic hepatitis C virus infection: A population-based Taiwanese cohort study

    Shu-Ming Chou; Hsing-Jung Yeh; Tzu-Min Lin et al.

    Frontiers in Immunology, Vol. 13 · 2022 · English · DOAJ Scopus

    BackgroundInterferon in combination with ribavirin has been the standard of care for chronic hepatitis C virus infection (HCV) for the past few decades. However, its effect on the risk of autoimmune diseases (ADs) among patients with HCV infection remains unclear. We assessed the potential…

  5. Journal Article

    Spinal cord injury and spinal fracture in patients with ankylosing spondylitis

    Po-Hsun Tu; Zhuo-Hao Liu; Mun-Chun Yeap et al.

    BMC Emergency Medicine, Vol. 22 No. 1 · 2022 · English · DOAJ Scopus

    Abstract Background Spinal cord injury (SCI) and spinal fracture are major complications in patients with ankylosing spondylitis (AS) who sustain spinal trauma. The purpose of this study was to investigate the incidence, predictors, and sequelae of spinal trauma in patients with AS. Methods This…

  6. Journal Article

    Dipeptidyl peptidase-4 inhibitors are associated with a lower risk of osteoarthritis in patients with type 2 diabetes

    Yu-Hsiu Chen; Virginia Byers Kraus; Yu-Sheng Chang et al.

    Therapeutic Advances in Musculoskeletal Disease, Vol. 18 · 2026 · English · DOAJ Scopus

    Background: Osteoarthritis (OA) is the most prevalent form of arthritis. Currently, no disease-modifying OA drugs are available. Increasing interest has focused on repurposing antidiabetic medications to prevent OA. Preclinical studies showed that dipeptidyl-peptidase 4 inhibitors (DPP-4is) may…

  7. Journal Article

    Psoriasis Risk Is Lower in Type 2 Diabetes Patients Using Dipeptidyl Peptidase‐4 Inhibitors or Thiazolidinediones Compared to Sulfonylureas

    Wei‐Sheng Chen; Tzu‐Min Lin; Yu‐Sheng Chang et al.

    Clinical and Translational Science, Vol. 18 No. 3 · 2025 · English · DOAJ Scopus

    ABSTRACT The risk of psoriasis in diabetic patients has rarely been explored. This study aims to compare the risk of incident psoriasis in patients with Type 2 diabetes (T2D) who initiate dipeptidyl peptidase‐4 inhibitors (DPP‐4is) or thiazolidinediones (TZDs) with those who initiate sulfonylureas…

  8. Journal Article

    Proton Pump Inhibitors Increase the Risk of Autoimmune Diseases: A Nationwide Cohort Study

    Sheng-Hong Lin; Yu-Sheng Chang; Tzu-Min Lin et al.

    Frontiers in Immunology, Vol. 12 · 2021 · English · DOAJ Scopus

    BackgroundPrevious study revealed proton pump inhibitors (PPIs) have an effect on gut microbiota. Alteration of the microbiome causes changes of the host immune system and then induces the development of autoimmune diseases (ADs). This study aimed to explore the possible association between PPIs…

  9. Journal Article

    Risk of incident autoimmune diseases in patients with thymectomy

    Tzu‐Min Lin; Yu‐Sheng Chang; Tsung‐Yun Hou et al.

    Annals of Clinical and Translational Neurology, Vol. 7 No. 7 · 2020 · English · DOAJ Scopus

    Abstract Objectives The data concerning the association between Tx and ADs remain unclear and are scarce. This study was undertaken to investigate whether people with Tx are more likely to develop ADs, compared to those without Tx. Methods Individuals who received Tx between 2002 and 2015 were…

  10. Journal Article

    Primary Sjogren syndrome increases the risk of bisphosphonate-related osteonecrosis of the jaw

    Pei-I Kuo; Tzu-Min Lin; Yu-Sheng Chang et al.

    Scientific Reports, Vol. 11 No. 1 · 2021 · English · DOAJ Scopus

    Abstract The risk of bisphosphonate-related osteonecrosis of the jaw (BRONJ) in primary Sjogren syndrome (pSS) has rarely been explored. To explore the association between BRONJ and pSS, we conducted a population-based propensity-score-matched cohort study using Taiwan’s National Health Insurance…

  11. Journal Article

    Hydroxychloroquine dose-dependently reduces the risk of incident diabetes in primary Sjögren syndrome patients on glucocorticoids: a nationwide population-based cohort study

    Wei-Sheng Chen; Hui-Ching Hsu; Tzu-Min Lin et al.

    Arthritis Research & Therapy, Vol. 27 No. 1 · 2025 · English · DOAJ Scopus

    Abstract Background Hydroxychloroquine (HCQ) is commonly used to treat Sjögren syndrome (SS). Glucocorticoids, which are commonly applied for managing primary SS (pSS), can disrupt glucose metabolism and increase diabetes mellitus (DM) risk. HCQ reduces DM risk in systemic lupus erythematosus and…